GGrantIndex
Sort

40,608 grants matching prostate cancer

Improved Detection of Prostate Cancer with Nanoparticle-based Ultrasound Contrast Agents Targeted to PSMA

$571,879
Agata A Exner · Case Western Reserve University · R01 · FY2019 · EB

Nutrition, Deregulation of Imprinted Genes

$571,872
Cathrine Hoyo · Duke University · R01 · FY2011 · ES

A novel AR degrader in castrate-resistant prostate cancer

$571,810
Hyeong-Reh Choi Kim · Wayne State University · R01 · FY2024 · CA

INHIBITING LYSINE-SPECIFIC DEMETHYLASE 1 ACTIVITY AS A POTENTIAL THERAPEUTIC TREATMENT FOR CASTRATION-RESISTANT PROSTATE CANCER

$571,801
University Of Mass At Boston · · FY2019 · Defense Health Agency

TRANSCRIPTOME OF METASTATIC PROSTATE CANCER

$571,708
Sidney Kimmel Cancer Center · R01 · FY2003 · CA

Techniques for MRI-Guided Cryosurgery of Prostate Cancer

$571,700
Stanford University · R01 · FY2003 · CA

The Prostate Cancer Tumor Microenvironment Exhibits Differentially Expressed Gene

$571,567
Dan Mercola · University Of California-Irvine · U01 · FY2014 · CA

ENHANCING PROSTATE CANCER IMMUNE RESPONSES BY PHARMACOLOGICAL REPROGRAMMING OF INTRATUMORAL MYELOID CELLS

$571,505
Thomas Jefferson University · · FY2016 · Department of the Army

Identifying Diagnostic Markers for Cervical, Breast, and Prostate Cancer

$571,414
Thomas Ried · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA

Research Program

$571,362
Alison Meredith Buttenheim · University Of Pennsylvania · P50 · FY2024 · CA

Identification of DNA methylation markers for risk of metastasis in localized pro

$571,325
Chun R. Chao · Kaiser Foundation Research Institute · R01 · FY2016 · CA

Clinical and Analytical Validation of Cancer Biomarkers

$571,325
Daniel W Chan · Johns Hopkins University · U24 · FY2018 · CA

Targeted Suppression of Microtubule Dynamics for Treatment of Metastatic Castration-Resistant Prostate Cancer

$571,271
Ali Azhdarinia · University Of Texas Hlth Sci Ctr Houston · R01 · FY2025 · CA

PKN1 AS NOVEL THERAPEUTIC TARGET IN ADVANCED PROSTATE CANCER

$571,246
The Cleveland Clinic Foundation · · FY2016 · Department of the Army

INTERPLAY OF CREB ATF2 IN IONIZING RADIATION-INDUCED NEUROENDOCRINE DIFFERENTIATION OF PROSTATE CANCER CELLS

$571,241
Purdue University · · FY2008 · Department of Defense

Engage: A Randomized Controlled Trial Testing the Efficacy of a Telehealth-Delivered Psychosocial Intervention to Decrease Symptom Interference in Patients with Advanced Cancer

$571,207
Joseph Giles Winger · Duke University · R01 · FY2025 · CA

Development of large-field-of-view hyperpolarized MRI

$571,198
Kayvan R Keshari · Sloan-Kettering Inst Can Research · R01 · FY2023 · CA

IMAGING CORE FACILITY BUDGET

$571,030
William M Southerland · Howard University · G12 · FY2018 · MD

Race, Prostate Cancer Treatment, and Treatment Decision Difficulty and Regret

$571,021
Willie Underwood · Roswell Park Cancer Institute Corp · R01 · FY2011 · CA

EVALUATING XMRV AS AN INDICATOR OF PROSTATE CANCER RISK OR PROGRESSION

$570,981
The Cleveland Clinic Foundation · · FY2008 · Department of Defense

Small molecule probes of MYC stability and function intumorigenesis

$570,930
Sarki A. Abdulkadir · Northwestern University At Chicago · R01 · FY2025 · CA

Antiretroviral Therapy Strategies to Lower Cancer Risk in HIV-Infected Persons

$570,918
Michael J Silverberg · Kaiser Foundation Research Institute · R01 · FY2013 · CA

Toxic Substances in the Environment

$570,847
Martyn T Smith · University Of California Berkeley · P42 · FY2019 · ES

Integrated Translational Genoproteomics Center at Washington University

$570,826
David G Mutch · Washington University · U10 · FY2015 · CA

ELUCIDATING A NOVEL PATHWAY TARGETED BY HDAC INHIBITORS AND ITS UTILITY IN PROSTATE CANCER THERAPY

$570,798
Duke University · · FY2009 · Department of the Army